⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ASPIRIN Trial Belgium

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: ASPIRIN Trial Belgium

Official Title: A Phase III Double-blind Placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

Study ID: NCT03464305

Conditions

Colon Cancer

Study Description

Brief Summary: The purpose of this study is to determine whether acetylsalicylic acid is effective on the recurrence and survival of colon cancer patients.

Detailed Description: The purpose of this study is to determine the effect of 80mg acetylsalicylic acid (given orally once daily for 5 years) on 5 year overall survival (OS) for stage II and III colon cancer patients of 45 years of age and older. Preclinical, epidemiologic and clinical evidence suggest that acetylsalicylic acid use may reduce overall cancer risk and mortality in colon cancer patients. It is a phase III double blind placebo controlled, randomized trial of adjuvant low-dose acetylsalicylic acid in colon cancer patients. Patients will be stratified at randomization by centre, age (\<70 and ≥70 years) chemotherapy use (any versus none) and disease stage.

Eligibility

Minimum Age: 45 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

AZ Rivierenland campus Bornem (Sint Jozefkliniek), Bornem, Antwerpen, Belgium

AZ Klina, Brasschaat, Antwerpen, Belgium

AZ Monica, Deurne, Antwerpen, Belgium

UZ Antwerpen, Edegem, Antwerpen, Belgium

AZ Rivierenland campus Rumst (Heilige Familie), Rumst, Antwerpen, Belgium

VITAZ (AZ Nikolaas), Sint-Niklaas, Oost-Vlaanderen, Belgium

Ziekenhuis Netwerk Antwerpen (ZNA), Antwerpen, , Belgium

Gasthuiszusters Ziekenhuizen (GZA), Antwerpen, , Belgium

Clinique Saint-Luc, Bouge, , Belgium

AZ Sint-Lucas, Brugge, , Belgium

CHIREC, Brussels, , Belgium

Grand Hôpital de Charleroi, Charleroi, , Belgium

AZ Sint-Blasius, Dendermonde, , Belgium

AZ Alma, Eeklo, , Belgium

AZ Sint-Dimpna, Geel, , Belgium

AZ Maria Middelares, Gent, , Belgium

Jessa Ziekenhuis, Hasselt, , Belgium

AZ Groeninge, Kortrijk, , Belgium

RZ Heilig Hart, Leuven, , Belgium

CH de l'Ardenne, Libramont, , Belgium

CHR de la Citadelle, Liège, , Belgium

CHU Ambroise Paré, Mons, , Belgium

CH de Mouscron, Mouscron, , Belgium

CHU UCL Namur Site de Sainte-Elisabeth, Namur, , Belgium

Clinique Saint-Pierre, Ottignies-Louvain-la-Neuve, , Belgium

AZ Glorieux, Ronse, , Belgium

AZ Sint-Trudo, Sint-Truiden, , Belgium

CHR Verviers, Verviers, , Belgium

OLV van Lourdes Ziekenhuis, Waregem, , Belgium

Contact Details

Name: Marc Peeters, Prof dr

Affiliation: University Hospital, Antwerp

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: